Role of18F-FDG PET/CT in pre and post treatment evaluation in head and neck carcinoma
Open Access
- 1 January 2014
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Radiology
- Vol. 6 (5), 177-191
- https://doi.org/10.4329/wjr.v6.i5.177
Abstract
Head and neck cancer (HNC) ranks as the 6th most common cancer worldwide, with the vast majority being head and neck squamous cell carcinoma (HNSCC). The majority of patients present with complicated locally advanced disease (typically stage III and IV) requiring multidisciplinary treatment plans with combinations of surgery, radiation therapy and chemotherapy. Tumor staging is critical to decide therapeutic planning. Multiple challenges include accurate tumor localization with precise delineation of tumor volume, cervical lymph node staging, detection of distant metastasis as well as ruling out synchronous second primary tumors. Some patients present with cervical lymph node metastasis without obvious primary tumors on clinical examination or conventional cross sectional imaging. Treatment planning includes surgery, radiation, chemotherapy or combinations that could significantly alter the anatomy and physiology of this complex head and neck region, making assessment of treatment response and detection of residual/ recurrent tumor very difficult by clinical evaluation and computed tomography (CT) or magnetic resonance imaging (MRI). 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography/CT (18F-FDG PET/CT) has been widely used to assess HNC for more than a decade with high diagnostic accuracy especially in detection of initial distant metastasis and evaluation of treatment response. There are some limitations that are unique to PET/CT including artifacts, lower soft tissue contrast and resolution as compared to MRI, false positivity in post-treatment phase due to inflammation and granulation tissues, etc. The aim of this article is to review the roles of PET/CT in both pre and post treatment management of HNSCC including its limitations that radiologists must know. Accurate PET/CT interpretation is the crucial initial step that leads to appropriate tumor staging and treatment planning.Keywords
This publication has 65 references indexed in Scilit:
- Feasibility and Incremental Benefit of Puffed-Cheek 18F-FDG PET/CT on Oral Cancer PatientsClinical Nuclear Medicine, 2013
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Assessment of Occult Primary Head and Neck Cancers — An Audit and Review of Published StudiesClinical Oncology, 2012
- 18FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysisOral Oncology, 2011
- Anatomic sites at elevated risk of second primary cancer after an index head and neck cancerCancer Causes & Control, 2011
- Utility of PET in unknown primary with cervical metastasis: A retrospective studyIndian Journal of Cancer, 2011
- Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: A prospective clinical trialHead & Neck, 2010
- Identification of distant metastases with PET‐CT in patients with suspected recurrent head and neck cancerThe Laryngoscope, 2009
- The impact of18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosisThe British Journal of Radiology, 2008
- Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal CancerThe New England Journal of Medicine, 1991